Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Intensive, home-based and effective treatment of postnatal depression has been shown to be associated with positive child development.

Image courtesy of Shutterstock

Postnatal depression is a common experience for women after the birth of a baby, affecting at least 1 in 10 mothers in the UK. For some mothers feeling low may last for a relatively short period of time, whereas others can experience symptoms for many months. Postnatal depression can be associated with negative effects on the child and the risks are increased when the depression persists. Previous research suggests that treating maternal depression alone may not be sufficient to mitigate any possible effects on children’s development.

A team of researchers at the University of Oxford’s Department of Psychiatry, led by Alan Stein, conducted a randomised controlled treatment trial for women experiencing persistent depression in the postnatal period.

Read more (University of Oxford website)

Similar stories

Long COVID: vaccination could reduce symptoms, new research suggests

While evidence suggests that people who are vaccinated before they get COVID are less likely to develop long COVID than unvaccinated people, the effectiveness of vaccination on existing long COVID has been less clear.

Com-COV vaccine study to research third dose booster options for 12-to-15-year-olds

Researchers running the University of Oxford-led Com-COV programme have launched a further study of COVID-19 vaccination schedules in young people aged 12 to 15 – with a focus on assessing different options for a third dose booster vaccination.

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.